Hoffmann/Roche family
Profile being verified
What they look for
The Hoffmann-Roche family (main shareholder of Roche). An unmatched pharma and medtech network. Tickets are larger than a typical angel's. They look for companies that could one day be acquired by big pharma.
What puts them off
No clear healthcare dimension, direct competitor to Roche without an obvious advantage.
How to approach them
Via the Basel pharma network (NIBAC, BioValley). Warm introduction through the Roche or Novartis network.
Decision process
8–16 weeks. In-depth scientific due diligence.
Recent investments
Healthcare, biotech, medtech, with a focus on Basel.